Summary
Mylan Inc. said today profits increased to more than $58 million in the March-June quarter and signaled even stronger profits lie ahead for the rest of the year.
The Canonsburg-based generic drug manufacturer's profit compared with a loss of $16.3 million a year earlier. On a per-share basis, results equaled 19 cents, vs. minus 5 cents a year ago.See the full content of this document
Extract
Mylan Issues Rosy Earnings Report, Forecast for Months Ahead
Quarterly revenue increased 5.3 percent to nearly $1.27 billion, due largely to higher ...
See the full content of this document
Sponsored links
